InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Prestige Consumer Healthcare Inc.

PBH Clue Score46
United States Fiscal year ends March CIK 0001295947
$48.23 +0.75% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $48.23 −16.40% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue882.1Operating income205.6Net income69.4EPS, diluted1.30Fiscal year 2018Revenue1,041.2 +18.0%Operating income215.5Net income339.6 +389.3%EPS, diluted6.34 +387.7%Fiscal year 2019Revenue975.8 −6.3%Operating income67.5Net income−35.8 −110.5%EPS, diluted−0.69 −110.9%Fiscal year 2020Revenue963.0 −1.3%Operating income291.2Net income142.3EPS, diluted2.78Fiscal year 2021Revenue943.4 −2.0%Operating income297.4Net income164.7 +15.7%EPS, diluted3.25 +16.9%Fiscal year 2022Revenue1,086.8 +15.2%Operating income329.9Net income205.4 +24.7%EPS, diluted4.04 +24.3%Fiscal year 2023Revenue1,127.7 +3.8%Operating income−22.4Net income−82.3 −140.1%EPS, diluted−1.65 −140.8%Fiscal year 2024Revenue1,125.4 −0.2%Operating income342.4Net income209.3EPS, diluted4.17Fiscal year 2025Revenue1,137.8 +1.1%Operating income336.8Net income214.6 +2.5%EPS, diluted4.29 +2.9%Fiscal year 2026Revenue1,088.7 −4.3%Operating income309.4Net income190.3 −11.3%EPS, diluted3.91 −8.9%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue 882.1 1,041.2 975.8 963.0 943.4 1,086.8 1,127.7 1,125.4 1,137.8 1,088.7
Growth +18.0% −6.3% −1.3% −2.0% +15.2% +3.8% −0.2% +1.1% −4.3%
Operating income 205.6 215.5 67.5 291.2 297.4 329.9 −22.4 342.4 336.8 309.4
Net income 69.4 339.6 −35.8 142.3 164.7 205.4 −82.3 209.3 214.6 190.3
Growth +389.3% −110.5% +15.7% +24.7% −140.1% +2.5% −11.3%
EPS, diluted 1.30 6.34 −0.69 2.78 3.25 4.04 −1.65 4.17 4.29 3.91
Growth +387.7% −110.9% +16.9% +24.3% −140.8% +2.9% −8.9%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Gross margin56.7%Operating margin23.3%Net margin7.9%Free cash flow margin16.5%Fiscal year 2018Gross margin55.4%Operating margin20.7%Net margin32.6%Free cash flow margin19.0%Fiscal year 2019Gross margin56.9%Operating margin6.9%Net margin−3.7%Free cash flow margin18.3%Fiscal year 2020Gross margin57.3%Operating margin30.2%Net margin14.8%Free cash flow margin21.0%Fiscal year 2021Gross margin58.0%Operating margin31.5%Net margin17.5%Free cash flow margin22.6%Fiscal year 2022Gross margin57.1%Operating margin30.4%Net margin18.9%Free cash flow margin23.0%Fiscal year 2023Gross margin55.4%Operating margin−2.0%Net margin−7.3%Free cash flow margin19.7%Fiscal year 2024Gross margin55.5%Operating margin30.4%Net margin18.6%Free cash flow margin21.3%Fiscal year 2025Gross margin55.8%Operating margin29.6%Net margin18.9%Free cash flow margin21.4%Fiscal year 2026Gross margin54.7%Operating margin28.4%Net margin17.5%Free cash flow margin22.6%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Gross margin 56.7% 55.4% 56.9% 57.3% 58.0% 57.1% 55.4% 55.5% 55.8% 54.7%
Operating margin 23.3% 20.7% 6.9% 30.2% 31.5% 30.4% −2.0% 30.4% 29.6% 28.4%
Net margin 7.9% 32.6% −3.7% 14.8% 17.5% 18.9% −7.3% 18.6% 18.9% 17.5%
Free cash flow margin 16.5% 19.0% 18.3% 21.0% 22.6% 23.0% 19.7% 21.3% 21.4% 22.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow148.7Capital expenditure−3.0Free cash flow145.7Buybacks0.0Fiscal year 2018Operating cash flow210.1Capital expenditure−12.5Free cash flow197.6 +35.6%Buybacks0.0Fiscal year 2019Operating cash flow189.3Capital expenditure−10.5Free cash flow178.8 −9.5%Buybacks−50.0Fiscal year 2020Operating cash flow217.1Capital expenditure−14.6Free cash flow202.6 +13.3%Buybacks−56.7Fiscal year 2021Operating cash flow235.6Capital expenditure−22.2Free cash flow213.4 +5.3%Buybacks−11.9Fiscal year 2022Operating cash flow259.9Capital expenditure−9.6Free cash flow250.3 +17.3%Buybacks0.0Fiscal year 2023Operating cash flow229.7Capital expenditure−7.8Free cash flow221.9 −11.3%Buybacks−50.0Fiscal year 2024Operating cash flow248.9Capital expenditure−9.6Free cash flow239.4 +7.9%Buybacks−25.0Fiscal year 2025Operating cash flow251.5Capital expenditure−8.2Free cash flow243.3 +1.6%Buybacks−51.5Fiscal year 2026Operating cash flow257.6Capital expenditure−11.2Free cash flow246.4 +1.3%Buybacks−156.3
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow 148.7 210.1 189.3 217.1 235.6 259.9 229.7 248.9 251.5 257.6
Capital expenditure −3.0 −12.5 −10.5 −14.6 −22.2 −9.6 −7.8 −9.6 −8.2 −11.2
Free cash flow 145.7 197.6 178.8 202.6 213.4 250.3 221.9 239.4 243.3 246.4
Growth +35.6% −9.5% +13.3% +5.3% +17.3% −11.3% +7.9% +1.6% +1.3%
Buybacks 0.0 0.0 −50.0 −56.7 −11.9 0.0 −50.0 −25.0 −51.5 −156.3

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash41.9Total debt2,193.7Net cash (debt)−2,151.9Shareholders’ equity822.5Debt to equity2.67Fiscal year 2018Cash32.5Total debt1,993.0Net cash (debt)−1,960.4Shareholders’ equity1,178.6Debt to equity1.69Fiscal year 2019Cash27.5Total debt1,798.6Net cash (debt)−1,771.1Shareholders’ equity1,095.8Debt to equity1.64Fiscal year 2020Cash94.8Total debt1,730.3Net cash (debt)−1,635.5Shareholders’ equity1,171.0Debt to equity1.48Fiscal year 2021Cash32.3Total debt1,479.7Net cash (debt)−1,447.4Shareholders’ equity1,358.3Debt to equity1.09Fiscal year 2022Cash27.2Total debt1,476.7Net cash (debt)−1,449.5Shareholders’ equity1,577.6Debt to equity0.94Fiscal year 2023Cash58.5Total debt1,345.8Net cash (debt)−1,287.3Shareholders’ equity1,447.1Debt to equity0.93Fiscal year 2024Cash46.5Total debt1,125.8Net cash (debt)−1,079.3Shareholders’ equity1,655.1Debt to equity0.68Fiscal year 2025Cash97.9Total debt992.4Net cash (debt)−894.5Shareholders’ equity1,834.9Debt to equity0.54Fiscal year 2026Cash63.9Total debt994.0Net cash (debt)−930.1Shareholders’ equity1,887.5Debt to equity0.53
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash 41.9 32.5 27.5 94.8 32.3 27.2 58.5 46.5 97.9 63.9
Total debt 2,193.7 1,993.0 1,798.6 1,730.3 1,479.7 1,476.7 1,345.8 1,125.8 992.4 994.0
Net cash (debt) −2,151.9 −1,960.4 −1,771.1 −1,635.5 −1,447.4 −1,449.5 −1,287.3 −1,079.3 −894.5 −930.1
Shareholders’ equity 822.5 1,178.6 1,095.8 1,171.0 1,358.3 1,577.6 1,447.1 1,655.1 1,834.9 1,887.5
Debt to equity 2.67 1.69 1.64 1.48 1.09 0.94 0.93 0.68 0.54 0.53

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending March, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Mar 2017 FY2018 31 Mar 2018 FY2019 31 Mar 2019 FY2020 31 Mar 2020 FY2021 31 Mar 2021 FY2022 31 Mar 2022 FY2023 31 Mar 2023 FY2024 31 Mar 2024 FY2025 31 Mar 2025 FY2026 31 Mar 2026
Revenue and profit
882.1 1,041.2 975.8 963.0 943.4 1,086.8 1,127.7 1,125.4 1,137.8 1,088.7
Growth +18.0% −6.3% −1.3% −2.0% +15.2% +3.8% −0.2% +1.1% −4.3%
381.8 464.7 420.2 410.8 395.9 466.2 502.4 500.9 503.3 493.1
500.3 576.5 555.6 552.2 547.5 620.6 625.3 624.4 634.5 595.6
Growth +15.2% −3.6% −0.6% −0.9% +13.4% +0.7% −0.1% +1.6% −6.1%
89.1 85.4 89.8 89.1 83.1 107.5 107.4 106.2 108.2 116.4
205.6 215.5 67.5 291.2 297.4 329.9 −22.4 342.4 336.8 309.4
Growth +4.8% −68.7% +331.3% +2.1% +10.9% −106.8% −1.7% −8.1%
110.9 107.1 −38.1 191.2 204.1 262.5 −93.9 276.0 284.2 257.5
41.5 −232.5 −2.3 48.9 39.4 57.1 −11.6 66.7 69.6 67.2
69.4 339.6 −35.8 142.3 164.7 205.4 −82.3 209.3 214.6 190.3
Growth +389.3% −110.5% +15.7% +24.7% −140.1% +2.5% −11.3%
Per share
1.31 6.40 −0.69 2.81 3.28 4.09 −1.65 4.21 4.32 3.93
1.30 6.34 −0.69 2.78 3.25 4.04 −1.65 4.17 4.29 3.91
Growth +387.7% −110.9% +16.9% +24.3% −140.8% +2.9% −8.9%
53.0 53.1 52.1 50.7 50.2 50.3 49.9 49.8 49.7 48.5
53.4 53.5 52.1 51.1 50.6 50.8 49.9 50.2 50.1 48.7
Growth +0.3% −2.7% −1.8% −1.0% +0.5% −1.9% +0.6% −0.2% −2.7%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 2.9% a year over five years, and earnings per share grew 3.8% a year.
  • The diluted share count fell 3.7% in five years, so buybacks did some of the work per share.
  • Operating margin is down 3.1 points on five years ago, at 28.4%.
  • A net loss in 2 of 10 years on file.